StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SKUE.OL$330.00+0.29%
Fair $330.00+0.0%

SKUE.OL

Skue Sparebank

Financial Services / Banks - RegionalOslo

$330.00

+0.95 (+0.29%)

Fairly Valued+0.0%Fair Value $330.00Fund rank 23/100 · Data gapFallback financials|
SA 30/D
F-Score: 5/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 35.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

30/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · SKUE.OLLocal privado en este navegador · Skue Sparebank
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.9B

P/E

15.5x

↑

EV/EBITDA

N/A

•

ROE

7.5%

↑

Gross Margin

N/A

•

Debt/Equity

1.18

↑
52-Week Range$330
$305$369

TradingView lightweight chart

SKUE.OL price, volumen y niveles de valoración

Último $333.95Periodo +286.1%
Fair value: $330.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+20.9%

FCF CAGR

—

FCF margin

212.4%

FCF / Net income

5.11x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $727.6M · net income $302.5M · FCF $1.55B

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

41.6%-0.6% pts

FCF margin

212.4%+359.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$727.6M$727.6M$569.2M$491.6M$412.0M
Net Income$302.5M$302.5M$327.9M$206.7M$173.9M
EPS22.2822.2832.5298.7983.14
Net Margin41.6%41.6%57.6%42.0%42.2%
Balance Sheet
Debt/Equity1.181.181.601.882.01
Cash Flow
Free Cash Flow$1.55B$1.55B$-13.2M$-14.7M$-604.4M
Returns
ROE7.5%7.5%10.5%9.1%8.5%
Valuation
P/E15.5415.548.612.372.77
P/B0.480.480.210.220.24
Growth & Yield
Revenue Growth27.8%27.8%15.8%19.3%—
EPS Growth-31.5%-31.5%-67.1%18.8%—
Dividend Yield6.7%6.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

9.5%

razonable

EPS terminal req.

$29.28

Spread vs growth

-41.0%

5Y implied EPS CAGR

9.7%

razonable

EPS terminal req.

$35.43

Spread vs growth

-41.2%

10Y implied EPS CAGR

9.9%

razonable

EPS terminal req.

$57.06

Spread vs growth

-41.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +9.4%

Total return

+9.4%

Start / end P/E

10.0x → 15.0x

EPS bridge

32.52 → 22.28

Residual

-15.7%

EPS growth-31.5%
Multiple rerating+50.0%
Dividend+6.7%
Residual / FX / buybacks / cross-term-15.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.